These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

551 related articles for article (PubMed ID: 31412684)

  • 1. Application of Highly Immunocompromised Mice for the Establishment of Patient-Derived Xenograft (PDX) Models.
    Okada S; Vaeteewoottacharn K; Kariya R
    Cells; 2019 Aug; 8(8):. PubMed ID: 31412684
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Establishment of a Patient-Derived Tumor Xenograft Model and Application for Precision Cancer Medicine.
    Okada S; Vaeteewoottacharn K; Kariya R
    Chem Pharm Bull (Tokyo); 2018; 66(3):225-230. PubMed ID: 29491256
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An immune-humanized patient-derived xenograft model of estrogen-independent, hormone receptor positive metastatic breast cancer.
    Scherer SD; Riggio AI; Haroun F; DeRose YS; Ekiz HA; Fujita M; Toner J; Zhao L; Li Z; Oesterreich S; Samatar AA; Welm AL
    Breast Cancer Res; 2021 Oct; 23(1):100. PubMed ID: 34717714
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Establishment and evaluation of retroperitoneal liposarcoma patient-derived xenograft models: an ideal model for preclinical study.
    Xu C; Yan L; An Q; Zhang S; Guan X; Wang Z; Lv A; Liu D; Liu F; Dong B; Zhao M; Tian X; Hao C
    Int J Med Sci; 2022; 19(8):1241-1253. PubMed ID: 35928724
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patient-Derived Xenograft Models in Cervical Cancer: A Systematic Review.
    Tanaka T; Nishie R; Ueda S; Miyamoto S; Hashida S; Konishi H; Terada S; Kogata Y; Sasaki H; Tsunetoh S; Taniguchi K; Komura K; Ohmichi M
    Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502278
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Testing Cancer Immunotherapy in a Human Immune System Mouse Model: Correlating Treatment Responses to Human Chimerism, Therapeutic Variables and Immune Cell Phenotypes.
    Marín-Jiménez JA; Capasso A; Lewis MS; Bagby SM; Hartman SJ; Shulman J; Navarro NM; Yu H; Rivard CJ; Wang X; Barkow JC; Geng D; Kar A; Yingst A; Tufa DM; Dolan JT; Blatchford PJ; Freed BM; Torres RM; Davila E; Slansky JE; Pelanda R; Eckhardt SG; Messersmith WA; Diamond JR; Lieu CH; Verneris MR; Wang JH; Kiseljak-Vassiliades K; Pitts TM; Lang J
    Front Immunol; 2021; 12():607282. PubMed ID: 33854497
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor characteristics associated with engraftment of patient-derived non-small cell lung cancer xenografts in immunocompromised mice.
    Chen Y; Zhang R; Wang L; Correa AM; Pataer A; Xu Y; Zhang X; Ren C; Wu S; Meng QH; Fujimoto J; Jensen VB; Antonoff MB; Hofstetter WL; Mehran RJ; Pisimisis G; Rice DC; Sepesi B; Vaporciyan AA; Walsh GL; Swisher SG; Roth JA; Heymach JV; Fang B
    Cancer; 2019 Nov; 125(21):3738-3748. PubMed ID: 31287557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microsatellite instability-high colorectal cancer patient-derived xenograft models for cancer immunity research.
    Suto H; Funakoshi Y; Nagatani Y; Imamura Y; Toyoda M; Kiyota N; Matsumoto H; Tanaka S; Takai R; Hasegawa H; Yamashita K; Matsuda T; Kakeji Y; Minami H
    J Cancer Res Ther; 2021; 17(6):1358-1369. PubMed ID: 34916366
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of anti-PD-1-based therapy against triple-negative breast cancer patient-derived xenograft tumors engrafted in humanized mouse models.
    Rosato RR; Dávila-González D; Choi DS; Qian W; Chen W; Kozielski AJ; Wong H; Dave B; Chang JC
    Breast Cancer Res; 2018 Sep; 20(1):108. PubMed ID: 30185216
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Establishment of a patient-derived xenograft model and cell line of malignant transformation of mature cystic teratoma of the ovary.
    Tamauchi S; Suzuki S; Xuboya C; Yoshihara M; Yoshida K; Ikeda Y; Yoshikawa N; Kajiyama H; Kikkawa F
    J Obstet Gynaecol Res; 2021 Feb; 47(2):713-719. PubMed ID: 33300248
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Establishment of Humanized Mice from Peripheral Blood Mononuclear Cells or Cord Blood CD34+ Hematopoietic Stem Cells for Immune-Oncology Studies Evaluating New Therapeutic Agents.
    Verma B; Wesa A
    Curr Protoc Pharmacol; 2020 Jun; 89(1):e77. PubMed ID: 32453514
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of immune responses to anti-PD-1 mono and combination immunotherapy in hematopoietic humanized mice implanted with tumor xenografts.
    Capasso A; Lang J; Pitts TM; Jordan KR; Lieu CH; Davis SL; Diamond JR; Kopetz S; Barbee J; Peterson J; Freed BM; Yacob BW; Bagby SM; Messersmith WA; Slansky JE; Pelanda R; Eckhardt SG
    J Immunother Cancer; 2019 Feb; 7(1):37. PubMed ID: 30736857
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Establishment and characterization of a non-gestational choriocarcinoma patient-derived xenograft model.
    Oda Y; Niimi K; Yoshida K; Tamauchi S; Yokoi A; Yasui Y; Nishiko Y; Shibata M; Shimizu Y; Yoshihara M; Ikeda Y; Yoshikawa N; Nishino K; Yamamoto E; Kajiyama H
    BMC Cancer; 2023 Nov; 23(1):1103. PubMed ID: 37957624
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Breast Cancer Xenograft Murine Models.
    Fernando W; Coyle KM; Marcato P
    Methods Mol Biol; 2022; 2508():31-44. PubMed ID: 35737231
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Orthotopic Implantation Achieves Better Engraftment and Faster Growth Than Subcutaneous Implantation in Breast Cancer Patient-Derived Xenografts.
    Okano M; Oshi M; Butash A; Okano I; Saito K; Kawaguchi T; Nagahashi M; Kono K; Ohtake T; Takabe K
    J Mammary Gland Biol Neoplasia; 2020 Mar; 25(1):27-36. PubMed ID: 32109311
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Representation of genomic intratumor heterogeneity in multi-region non-small cell lung cancer patient-derived xenograft models.
    Hynds RE; Huebner A; Pearce DR; Hill MS; Akarca AU; Moore DA; Ward S; Gowers KHC; Karasaki T; Al Bakir M; Wilson GA; Pich O; Martínez-Ruiz C; Hossain ASMM; Pearce SP; Sivakumar M; Ben Aissa A; Grönroos E; Chandrasekharan D; Kolluri KK; Towns R; Wang K; Cook DE; Bosshard-Carter L; Naceur-Lombardelli C; Rowan AJ; Veeriah S; Litchfield K; Crosbie PAJ; Dive C; Quezada SA; Janes SM; Jamal-Hanjani M; Marafioti T; ; McGranahan N; Swanton C
    Nat Commun; 2024 May; 15(1):4653. PubMed ID: 38821942
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Establishment and genetically characterization of patient-derived xenograft models of cervical cancer.
    Zou S; Ye M; Zhang JA; Ji H; Chen Y; Zhu X
    BMC Med Genomics; 2022 Sep; 15(1):191. PubMed ID: 36076209
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Humanized mice in studying efficacy and mechanisms of PD-1-targeted cancer immunotherapy.
    Wang M; Yao LC; Cheng M; Cai D; Martinek J; Pan CX; Shi W; Ma AH; De Vere White RW; Airhart S; Liu ET; Banchereau J; Brehm MA; Greiner DL; Shultz LD; Palucka K; Keck JG
    FASEB J; 2018 Mar; 32(3):1537-1549. PubMed ID: 29146734
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lenvatinib inhibits the growth of gastric cancer patient-derived xenografts generated from a heterogeneous population.
    Karalis JD; Yoon LY; Hammer STG; Hong C; Zhu M; Nassour I; Ju MR; Xiao S; Castro-Dubon EC; Agrawal D; Suarez J; Reznik SI; Mansour JC; Polanco PM; Yopp AC; Zeh HJ; Hwang TH; Zhu H; Porembka MR; Wang SC
    J Transl Med; 2022 Mar; 20(1):116. PubMed ID: 35255940
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative utility of NRG and NRGS mice for the study of normal hematopoiesis, leukemogenesis, and therapeutic response.
    Barve A; Casson L; Krem M; Wunderlich M; Mulloy JC; Beverly LJ
    Exp Hematol; 2018 Nov; 67():18-31. PubMed ID: 30125602
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.